Belite Bio, Inc
BLTE
$64.03
-$1.33-2.04%
12/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 145.15M | 88.16M | -- | -- | -- |
Total Receivables | 575.00K | 836.00K | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 1.33M | 916.00K | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 19.00K | 31.00K | 56.14M | 59.14M | 38.42M |
Total Current Assets | 147.07M | 89.94M | 56.14M | 59.14M | 38.42M |
|
|||||
Total Current Assets | 147.07M | 89.94M | 56.14M | 59.14M | 38.42M |
Net Property, Plant & Equipment | 965.00K | 1.30M | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 31.00K | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 4.06M | 3.40M | 1.46M | 1.56M | 1.40M |
Total Assets | 152.13M | 94.64M | 57.60M | 60.70M | 39.82M |
|
|||||
Total Accounts Payable | -- | -- | -- | -- | -- |
Total Accrued Expenses | 5.47M | 3.18M | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 276.00K | 308.00K | -- | -- | -- |
Total Finance Division Other Current Liabilities | 302.00K | 149.00K | 4.80M | 4.98M | 4.65M |
Total Other Current Liabilities | 302.00K | 149.00K | 4.80M | 4.98M | 4.65M |
Total Current Liabilities | 6.05M | 3.63M | 4.80M | 4.98M | 4.65M |
|
|||||
Total Current Liabilities | 6.05M | 3.63M | 4.80M | 4.98M | 4.65M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 261.00K | 578.00K | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 6.31M | 4.21M | 4.80M | 4.98M | 4.65M |
|
|||||
Common Stock & APIC | 254.13M | 162.31M | 52.79M | 55.72M | 35.17M |
Retained Earnings | -107.65M | -71.50M | -- | -- | -- |
Treasury Stock & Other | -660.00K | -374.00K | -- | -- | -- |
Total Common Equity | 145.82M | 90.43M | 52.79M | 55.72M | 35.17M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 145.82M | 90.43M | 52.79M | 55.72M | 35.17M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 145.82M | 90.43M | 52.79M | 55.72M | 35.17M |
|